Mrsa | Codevax, Inc. Names Stephen D. Chubb To Board Of Directors


Codevax, Inc. a U.S. vaccine development company focused on preventing hospital acquired infections including MRSA and Acinetobactor baumannii is expanding. Stephen D. Chubb has been appointed to the Codevax Board of Directors.

Rochester, NY (PRWEB) June 22, 2011

“We are very pleased to announce Steve’s addition to the board,” said Steve Dewhurst, PhD., Codevax Chairman and President, and Chair of Microbiology and Immunology. “Steve is without a doubt a well respected entrepreneur and has keen business acumen. We are excited about the contribution he will make to our business strategy and strategic growth plans for immunotherapy of infectious diseases – specifically MRSA prevention and treatment.”

Chubb is a seasoned executive with more than 30 years of experience in the medical devices and biotechnology industries. He is currently a business advisor to Catalyst Healthcare Ventures, LLP and a Director on the boards of Allegro Diagnostics Corp., Immunetics, Inc., and Charles River Laboratories International. Chubb is the former Chairman of the Board to Mount Auburn Hospital, Cambridge, MA.


“Debilitating and lethal infections resulting from routine surgeries have become a serious medical problem,” said Chubb.”Codevax has been supporting researchers at the University of Rochester Medical School, who have identified particularly susceptible targets on the most pernicious of these infection causing organisms and are working on a vaccine to eliminate them. It is a privilege to be associated with Codevax in assisting the company in bringing this important therapy to market quickly.”

Previously, Chubb was the Chairman and Chief Executive Officer of Matritech, Inc., a proteomics-based diagnostics company for the early detection of bladder cancer. Earlier in his career, he was President and Chief Executive Officer of T Cell Sciences, Inc.; President of the Hyland Diagnostics Division at Baxter Corporation; and President and Chief Executive Officer of Cytogen Corp. Chubb is a Certified Public Accountant, holds an


Click here to view rest of article from original site

Hospital Infection: From Miasmas To Mrsa  by Graham A. J. Ayliffe And Hospital Infection: From Miasmas To Mrsa  by Graham A. J. Ayliffe And
ary P. English
12 new from $69.42
X3 Clean Hand Sanitizer Mini Spray, 12-count .27-ounce Bottles  by X3 X3 Clean Hand Sanitizer Mini Spray, 12-count .27-ounce Bottles  by X3
lean
2 new from $12.25



Facebook Twitter Email